Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Elan Corporation News

This is an old version of this news section. Please find the new version yourself or contact us.

TAKE THIS POLL
Regardless of your general preferences, which U.S. presidential candidate's Iraq policy do you support? (Jul. 15, 2008) John McCain's policy. Barack Obama's 's policy. Don't know.

Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidan 23 Jul 2008 11:50 GMT
... a unique heartworm preventative, to the U.S. veterinary market. Finally, in June, Wyeth and Elan Corporation, plc announced encouraging preliminary findings from a Phase 2 study of bapineuzumab (AAB-001) in ...
Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance 23 Jul 2008 11:35 GMT
... a unique heartworm preventative, to the U.S. veterinary market. Finally, in June, Wyeth and Elan Corporation, plc (NYSE: ) announced encouraging preliminary findings from a Phase 2 study of bapineuzumab ...
Biogen Idec and Elan Celebrate Second Anniversary of Tysabri for the Treatment of Multiple Sclerosis 22 Jul 2008 12:31 GMT
... CAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Jul 22, 2008 - Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced the two-year anniversary of TYSABRI(R) (natalizumab) as a treatment ...
Elan Corporation PLC UK Regulatory Announcement: Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results 22 Jul 2008 06:30 GMT
... shortcut. Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) today announced that the companies will hold ...
Elan Pharmcuticals PLC UK Regulatory Announcement: Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis 22 Jul 2008 06:30 GMT
... s Growth with More Than 31,800 Patients Receiving Treatment Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced the two-year anniversary of TYSABRI Specifically, as of the ...

Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results 22 Jul 2008 06:25 GMT
... archived version of the call and slides will be available at the same URLs. Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives ...
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis 22 Jul 2008 06:25 GMT
... arthritis. For product labeling, press releases and additional information about the company, please visit Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives ...
Kofax lower after update 21 Jul 2008 15:14 GMT
... 19.50p +9.86% Torotrak (TRK) 20.00p +9.59% Psion (PON) 86.25p +7.14% Vernalis (VER) 4.65p +5.68% Elan Corporation (ELA) � 22.27 +5.45% Corin Group (CRG) 164.50p +5.28% SDL International (SDL) 337.00p +4.01% ...
Detica rises on offer talks 21 Jul 2008 11:15 GMT
... +8.39% ARC International (ARK) 19.00p +7.04% Emblaze (BLZ) 34.00p +6.25% Vernalis (VER) 4.65p +5.68% Elan Corporation (ELA) � 22.15 +4.88% Filtronic (FTC) 75.25p +4.51% Antisoma (ASM) 23.25p +3.33% Sinclair Pharma ...